Beta-glucan production via segmented enzyme overexpression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing beta-glucans, such as schizophyllan, are limited by low yields and efficiency in genetically modified microorganisms, requiring improved genetic modification techniques to enhance enzyme activity and increase polymer production.
Innovation Solution
Genetically modified microorganisms, specifically Schizophyllum commune, are engineered to overexpress phosphoglucomutase, UTP-glucose-1-phosphate uridyltransferase, and branching enzyme, with multiple copies of relevant genes introduced to increase enzyme activity, resulting in higher production of beta-glucan polymers like schizophyllan.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional genetic modification methods are used to produce beta-glucans, then the microorganisms can produce the polymer, but the yield and efficiency remain low
Solution Approach 1:
The patent segments the beta-glucan synthesis pathway into three key enzymatic steps and modifies each independently: (1) phosphoglucomutase for glucose-1-phosphate conversion, (2) UTP-glucose-1-phosphate uridyltransferase for UDP-glucose formation, and (3) branching enzyme for schizophyllan polymerization. This segmented approach allows targeted optimization of each pathway component to overcome the low yield limitation while maintaining manageable genetic modification complexity through modular engineering.
Solution Approach 2:
The patent applies parameter changes by introducing multiple copies of genes encoding the three key enzymes to increase their expression levels and enzymatic activity. Specifically, it overexpresses phosphoglucomutase, UTP-glucose-1-phosphate uridyltransferase, and branching enzyme, thereby changing the kinetic parameters of the synthesis pathway. This parameter optimization directly addresses the low productivity issue by enhancing the rate-limiting steps without requiring complete pathway reconstruction.
2Productivity
If enzyme activity is increased through genetic modification, then polymer production increases, but the metabolic pathway efficiency needs optimization
Solution Approach 1:
The patent applies preliminary action by pre-optimizing the metabolic pathway before main polymer synthesis. It first enhances the activity of phosphoglucomutase to ensure adequate glucose-1-phosphate supply, then optimizes UTP-glucose-1-phosphate uridyltransferase to maximize UDP-glucose formation. This preliminary optimization of upstream metabolic steps ensures that the branching enzyme has sufficient substrate availability, thereby improving overall pathway efficiency and reducing metabolic energy loss during schizophyllan production.
Solution Approach 2:
The patent uses UDP-glucose as a key intermediary substance that connects the metabolic pathway to the polymer synthesis pathway. By overexpressing UTP-glucose-1-phosphate uridyltransferase, the patent enhances the conversion of glucose-1-phosphate to UDP-glucose, creating an abundant intermediate pool that efficiently feeds the branching enzyme. This intermediary optimization ensures smooth metabolic flow and minimizes energy loss by preventing substrate bottlenecks in the synthesis pathway.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified microorganisms produce at least 1.5 times more beta-glucan polymer compared to non-modified controls, with increased enzyme activity leading to enhanced schizophyllan yields and reduced ethanol synthesis, indicating more direct glucose metabolism into the schizophyllan pathway.
Implementation Method 1
The gene product phosphoglucomutase means an enzyme that transfers a phosphate group on an α-D-glucose monomer from the 1' to the 6' position in the forward direction or the 6' to the 1' position in the reverse direction
Implementation Method 2
The gene product UTP-glucose-1-phosphate uridyltrasferase... is an enzyme associated with glycogenesis. It synthesizes UDP-glucose from glucose-1-phosphate and UTP; The reaction catalyzed by it is: glucose-1-phosphate + UTP -> UDP-glucose + pyrophosphate
Implementation Method 3
The gene product branching enzyme means Glycosyltransferases, Branching Enzymes... which catalyse the formation of a beta-D-(1-3)-glucopyranosyl units having a single beta-D-glucopyranosyl unit (1-6) linked to a beta-D-glucopyranosyl unit of the linear main chain
Data Source
AI summary
Process for producing a polymer consisting of a linear main chain of beta-D-(1-3)- glucopyranosyl units having a single beta-D-glucopyranosyl unit (1-6) linked to a beta-D- glucopyranosyl unit of the linear main chain with an average branching degree of about 0.3, said process comprising the steps of: (i) culturing in a medium a genetically modified microorganism capable of producing a polymer consisting of a linear main chain of beta-D-(1-3)-glucopyranosyl units having a single beta-D-glucopyranosylunit (1-6) linked to a beta-D-glucopyranosyl unit of the linear main chain with an average branching degree of about 0.3, wherein the modification confers an increased activity -compared to a non-modified control microorganism of the same strain -of at least two gene products selected from the group consisting of (a) hexokinase, (b) phosphoglucomutase,. (c) UTP-glucose-1-phosphate uridyltrasferase, (d) 1,3–beta-glucan synthase (e) branching enzyme; under conditions allowing said microorganism to produce said polymer; (ii) optionally recovering said polymer from the medium.